ETS1 and ovarian carcinoma: In addition, the survival analysis of cases extracted from the GSE9891, GSE3149, and GSE63885 showed that ETS1 expression was positively associated with poor prognosis in patients with ovarian cancer (Fig. 1C and Supplementary Fig. S2A), however, the survival analysis in the GSE27651, GSE15622, GSE30161, and TCGA ovarian cancer cohorts did not reach statistical significance (Supplementary Fig. S2B–E).